Arteris, Inc. (NASDAQ:AIP) CFO Sells $36,750.00 in Stock

Arteris, Inc. (NASDAQ:AIPGet Free Report) CFO Nicholas B. Hawkins sold 5,000 shares of the stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $7.35, for a total value of $36,750.00. Following the transaction, the chief financial officer now owns 219,659 shares of the company’s stock, valued at $1,614,493.65. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Arteris Price Performance

Arteris stock opened at $7.10 on Friday. Arteris, Inc. has a 12 month low of $4.20 and a 12 month high of $9.54. The stock’s 50 day moving average is $7.52 and its 200-day moving average is $7.64. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $273.20 million, a price-to-earnings ratio of -6.89 and a beta of 1.11.

Arteris (NASDAQ:AIPGet Free Report) last released its earnings results on Thursday, August 1st. The company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.07). Arteris had a negative return on equity of 274.66% and a negative net margin of 68.37%. The business had revenue of $14.58 million for the quarter, compared to the consensus estimate of $13.68 million. During the same quarter in the previous year, the company earned ($0.25) earnings per share. Equities research analysts expect that Arteris, Inc. will post -0.9 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have issued reports on the stock. Rosenblatt Securities reaffirmed a “buy” rating and issued a $15.00 price objective on shares of Arteris in a research note on Monday, August 5th. Westpark Capital reissued a “buy” rating and set a $11.00 price target on shares of Arteris in a research report on Wednesday, July 31st.

Check Out Our Latest Report on AIP

Hedge Funds Weigh In On Arteris

Several institutional investors have recently added to or reduced their stakes in AIP. Vanguard Group Inc. raised its position in shares of Arteris by 0.3% during the first quarter. Vanguard Group Inc. now owns 1,146,224 shares of the company’s stock worth $8,390,000 after purchasing an additional 3,242 shares during the period. Renaissance Technologies LLC raised its position in shares of Arteris by 6.1% in the second quarter. Renaissance Technologies LLC now owns 114,700 shares of the company’s stock worth $861,000 after buying an additional 6,600 shares in the last quarter. The Manufacturers Life Insurance Company bought a new stake in shares of Arteris during the 2nd quarter valued at about $86,000. Algert Global LLC bought a new position in shares of Arteris in the 2nd quarter worth $115,000. Finally, GSA Capital Partners LLP increased its holdings in shares of Arteris by 26.9% in the 1st quarter. GSA Capital Partners LLP now owns 132,952 shares of the company’s stock worth $973,000 after buying an additional 28,165 shares during the last quarter. 64.36% of the stock is owned by institutional investors and hedge funds.

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Stories

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.